Dr. Dongyan Liu, MD

Dr. Liu practices at Greater Baltimore Medical Center in Baltimore, Maryland, part of GBMC HealthCare.

Dr. Liu's NPI, 1912391913, was assigned on March 27, 2015. Dr. Liu holds Maryland license D0092337.

Dr. Liu's primary practice is Greater Baltimore Medical Center, at 6701 North Charles Street, Baltimore, MD 21204 in Baltimore County. The practice phone is (443) 849-2000.

Dr. Liu's primary practice is Greater Baltimore Medical Center in Baltimore, Maryland, part of GBMC HealthCare. Dr. Liu is also affiliated with Frederick Health Hospital. The medical group on file is Greater Baltimore Medical Center (GBMC). Dmand AI also links Dr. Liu to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Liu practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Liu's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Liu is licensed in Maryland.

CMS data shows 83,547 Medicare services from Dr. Liu across 53 procedure codes in 2024, for 743 Medicare patients. Medicare paid $1,242,786 for them.

CMS counts 743 Medicare patients who saw Dr. Liu in 2024. The largest group is 65 to 74, with 319 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Liu's median patient age at 66, with 75% women.

In 2024, Dr. Liu wrote 562 Medicare Part D claims for 128 patients. 69% of them were for generic drugs. CMS names the drug for 425 of them, across 15 drugs with 11 or more claims each, at $892,060 in total drug cost. In 2023, CMS named 203 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Liu for performance year 2024, reported as part of a group. Dr. Liu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Liu as offering telehealth.

Dmand AI links 4 papers to Dr. Liu, published from 2016 to 2017. 2017 was the busiest year, with 2. Dr. Liu has published most often in J Community Hosp Intern Med Perspect. Dr. Liu's most frequent co-authors are Thomas Edward Bateman, MD, Elisabeth M. Carr, MD and Sahayini Arulrajah Kumar, MD.

CMS Open Payments shows 57 general payments to Dr. Liu from 27 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 67% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,028.